These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12555598)

  • 1. [Deleterious cardiac effects of serotonin in myocardial ischemia: role of naftidrofuryl].
    Kioueh I; Mosnier M; Bui-Xuan B; Frassati D; Descotes J; Timour Q
    Ann Cardiol Angeiol (Paris); 2001 Jun; 50(4):229-38. PubMed ID: 12555598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of naftidrofuryl, a 5-HT2 antagonist, on collateral vascular responses to serotonin and to platelet activation.
    Hollenberg NK; Nie Q
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S36-9. PubMed ID: 1369716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the efficacy and tolerance of naftidrofuryl in patients presenting with exertional angina. Multicenter double-blind versus placebo study].
    Hirsch JL; Bensoussan JJ; Mosnier M; Lehert P
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):137-45. PubMed ID: 12555338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of serotonergic neuronal systems in the anti-amnesic action of naftidrofuryl oxalate.
    Nabeshima T; Ichihara K; Tohyama K; Murase K; Suzuki T; Kameyama T
    Eur J Pharmacol; 1991 Nov; 205(1):55-61. PubMed ID: 1811997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of naftidrofuryl on the contraction and proliferation of cultured myocytes evoked by serotonin.
    Bodin P; Travo P
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S25-8. PubMed ID: 1369713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of the spasmogenic effect of exogenous and endogenous serotonin on isolated blood vessels by naftidrofuryl].
    Verheggen R; Schrör K
    Vasa Suppl; 1988; 24():5-10. PubMed ID: 3212604
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet aggregation after naftidrofuryl application in vitro and ex vivo.
    Kirsten R; Erdeg B; Moxter D; Hesse K; Breidert M; Nelson K
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):81-4. PubMed ID: 7757315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin, 5-HT2 receptors, and their blockade by naftidrofuryl: a targeted therapy of vascular diseases.
    Wiernsperger NF
    J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S37-43. PubMed ID: 7517475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of constriction of cerebral arterioles in vivo by naftidrofuryl. Action against serotonin and dinoprost.
    Rosenblum WI
    Arzneimittelforschung; 1987 May; 37(5):495-7. PubMed ID: 3476118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naftidrofuryl inhibits contractions to serotonin in intact and de-endothelialized cerebral arteries in vitro.
    Oudart N
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S45-8. PubMed ID: 1369718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of naftidrofuryl, a serotonergic antagonist, on erythrocyte aggregation.
    Nordt FJ; Jack W; Coull BM
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S29-32. PubMed ID: 1369714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic impact of the left ventricular pacing site during graded ischaemia in an open-chest pig model.
    Bordachar P; Labrousse L; Thambo JB; Reant P; Lafitte S; O'Neill MD; Jais P; Haissaguerre M; Clementy J; Dos Santos P
    Europace; 2008 Feb; 10(2):242-8. PubMed ID: 18256130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of naftidrofuryl in angiology].
    Kuznetsov MR; Kosykh IV; Iumin SM; Kunitsyn NV; Kuznetsova VF; Tolstikhin VIu; Magnitskiĭ LA
    Angiol Sosud Khir; 2014; 20(4):27-35. PubMed ID: 25490354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of naftidrofuryl on platelet-induced vasospasm in vitro. Role of antiserotonergic actions.
    Verheggen R; Schrör K
    Arzneimittelforschung; 1993 Mar; 43(3):330-4. PubMed ID: 8489562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanically induced changes in action potential duration and left ventricular segment length in acute regional ischaemia in the in situ porcine heart.
    Horner SM; Lab MJ; Murphy CF; Dick DJ; Zhou B; Harrison FG
    Cardiovasc Res; 1994 Apr; 28(4):528-34. PubMed ID: 8181042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous naftidrofuryl for critical limb ischaemia.
    Smith FB; Bradbury AW; Fowkes FG
    Cochrane Database Syst Rev; 2000; (2):CD002070. PubMed ID: 10796677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium--a profibrillatory or antifibrillatory drug depending on plasma concentration, heart rate and myocardial perfusion.
    Aupetit JF; Freysz M; Faucon G; Loufoua-Moundanga J; Coquelin H; Timour Q
    Acta Anaesthesiol Scand; 1997 Apr; 41(4):516-23. PubMed ID: 9150782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and physiological evidences for antiserotonergic properties of naftidrofuryl.
    Maloteaux JM; Haiech J; De Campeneere D; Berta P; Vidal N
    Arzneimittelforschung; 1986 Aug; 36(8):1194-8. PubMed ID: 3022761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serotonin antagonism and uterine activity].
    Lechner W; Sölder E; Kölle D
    Z Geburtshilfe Perinatol; 1991; 195(6):260-1. PubMed ID: 1776315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naftidrofuryl-driven regulation of endothelial ICAM-1 involves nitric oxide.
    Marconi A; Darquenne S; Boulmerka A; Mosnier M; D'Alessio P
    Free Radic Biol Med; 2003 Mar; 34(5):616-25. PubMed ID: 12614850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.